Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
658.30
16.4 (2.55%)
BSENSE

Nov 20

BSE+NSE Vol: 1.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Indegene
Suraksha Diagno.
Thyrocare Tech.
Vimta Labs
Sahajanand Medi
Tarsons Products
Suven Life Scie.
Nephrocare Healt
Vijaya Diagnost.
Metropolis Healt
Krsnaa Diagnost.
Why is Nephrocare Health Services Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.21%
  • Poor long term growth as Net Sales has grown by an annual rate of 15.80% and Operating profit at -30.62% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
With ROE of -0.8, it has a Very Expensive valuation with a 6.6 Price to Book Value
3
Reducing Promoter Confidence
  • Promoters have decreased their stake in the company by -5.54% over the previous quarter and currently hold 58.31% of the company
  • Promoters decreasing their stake may signify reduced confidence in the future of the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.80%
EBIT Growth (5y)
-30.62%
EBIT to Interest (avg)
1.85
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.63
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.84%
ROCE (avg)
5.12%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
51
Industry P/E
63
Price to Book Value
6.56
EV to EBIT
202.39
EV to EBITDA
70.14
EV to Capital Employed
10.18
EV to Sales
9.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.03%
ROE (Latest)
-0.80%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bearish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
OPERATING CF(Y)

Highest at Rs 132.90 Cr

NET SALES(Q)

Highest at Rs 303.40 cr

PBT LESS OI(Q)

At Rs 32.41 cr has Grown at 54.8% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 67.12 cr.

PAT(Q)

Highest at Rs 33.53 cr.

-5What is not working for the Company
INTEREST(Q)

At Rs 3.11 cr has Grown at 40.72%

Loading Valuation Snapshot...
Here's what is working for Nephrocare Healt
Operating Cash Flow - Annually
Highest at Rs 132.90 Cr and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Quarterly
Highest at Rs 303.40 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 32.41 cr has Grown at 54.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 20.94 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 33.53 cr has Grown at 57.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 21.28 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 67.12 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 33.53 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Nephrocare Healt
Interest - Quarterly
At Rs 3.11 cr has Grown at 40.72%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)